Estramustine-binding protein in meningioma

Acta Neuropathologica

Volumn 98, Issue 2, 1999, Pages 135-140

  Karlsson, Anna E ^a   Bergenheim, A Tommy ^a   Björk, Per ^b   Henriksson, Roger ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b Active Biotech Research AB   (Sweden)

Author keywords

Brain tumor; Chemotherapy; Prostatic binding protein

Indexed keywords

BINDING PROTEIN; ESTRAMUSTINE;

ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MENINGIOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RELAPSE; SCATCHARD PLOT; TUMOR GROWTH;

BLOTTING, WESTERN; CARRIER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IMMUNOHISTOCHEMISTRY; MENINGEAL NEOPLASMS; MENINGIOMA; PROSTATIC SECRETORY PROTEINS; RADIOIMMUNOASSAY;

EID: 0032877202     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010051061     Document Type: Article

References (47)

1. Adegbite AB, Khan MI, Paine KWE, Tan LK (1983) The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51-56
2. Andersson SB, Gunnarsson PO, Nilsson T, Forsell GP (1981) Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma. Eur J Drug Metab Pharmacokinet 6: 149-154
3. Bergenheim AT, Gunnarsson PO, Edman K, Schoultz E von, Hariz MI, Henriksson R (1993) Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans. Br J Cancer 67:358-361
4. Bergenheim AT, Björk P, Bergh J, Schoultz E von, Svedberg H, Henriksson R (1994) Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma. Cancer Res 54:4974-4979
5. Bergenheim AT, Zackrisson B, Elfverson J, Roos G, Henriksson R (1995) Radiosensitizing effect of estramustine in malignant glioma in vitro and in vivo. J Neurooncol 23: 191-200
6. Bichler KH, Fluchter SH, Nelde HJ, Björk P, Muntzing J (1989) An immunohistochemical technique for localization and semiquantitation of estramustine-binding protein (EMBP) in rat and human prostate. Prostate 14: 13-25
7. Bjermer L, Schoultz E von, Norberg B, Henriksson R (1988) Estramustine inhibits monocyte phagocytosis. Prostate 13:49-55
8. Björk P, Forsgren B, Gustafsson JA, Pousette A, Högberg B (1982) Partial characterization and "quantitation" of a human prostatic estramustine-binding protein. Cancer Res 42: 1935-1942
9. Björk PA, Fluchter SH, Nelde HJ (1988) Estramustine-binding protein - a marker for effect of therapy in prostatic carcinoma? Scand J Urol Nephrol [Suppl] 107:59-64
10. Björk P, Borg A, Fernö M, Nilsson S (1991) Expression and partial characterization of estramustine-binding protein (EMBP) in human breast cancer and malignant melanoma. Anticancer Res 11:1173-1182
11. Björk P, Jonsson U, Andrén-Sandberg A (1991) Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein. Pancreas 6:77-89
12. Björk P, Donn F, Glad C, Sundblad G, Vestberg M, Kalland T (1995) Purification of estramustine-binding protein and production of monoclonal antibodies to its different components. Prostate 27:70-83
13. Black P, Carroll R, Zhang J (1996) The molecular biology of hormone and growth factor receptors in meningiomas. Acta Neurochir (Wien) [Suppl] 65:50-53
14. Black PM (1991) Brain tumors. N Engl J Med 324: 1555-1564
15. Carter DB, Resnick MI (1982) High resolution analysis of human prostatic fluid by two-dimensional electrophoresis. Prostate 3:27-33
16. Eklöv S, Nilsson S, Larson A, Björk P, Hartley Asp B (1992) Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivo. Prostate 20:43-50
17. Engström KG, Grankvist K, Henriksson R (1991) Early morphological detection of estramustine cytotoxicity measured as alteration in cell size and shape by a new technique of microperifusion. Eur J Cancer 27:1288-1295
18. Forsgren B, Björk P, Carlström K, Gustafsson JA, Pousette A, Högberg B (1979) Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta. Proc Natl Acad Sci USA 76: 3149-3153
19. Forsgren B, Gustafsson JA, Pousette A, Högberg B (1979) Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol. Cancer Res 39:5155-5164
20. Guesdon J-L, Ternynck T, Avrameas S (1979) The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 27:1131-1139
21. Halper J, Colvard DS, Scheithauer BW, Jiang NS, Press MF, Graham ML, Riehl E, Laws ER Jr, Spelsberg TC (1989) Estrogen and progesterone receptors in meningiomas: comparison of nuclear binding, dextran-coated charcoal, and immunoperoxidase staining assays. Neurosurgery 25:546-552
22. Henriksson R, Bjermer L, Schoultz E von, Grankvist K (1990) The effect of estramustine on microtubuli is different from the direct action via oxygen radicals on DNA and cell membrane. Anticancer Res 10:303-309
23. Heyns W, Bossyns D (1983) A comparative study of estramustine and pregnenolone binding to prostatic binding protein: evidence for subunit cooperativity. J Steroid Biochem 19: 1689-1694
24. Högberg B, Björk P, Carlström K, Forsgren B, Gustavsson J-Å, Hökfelt T, Pousette Å (1979) The interaction of steroidal alkylating agents with binding components in the soluble fraction of the prostate. Prostate cancer and hormone receptors. Liss, New York, pp 181-199
25. Hsu DW, Efird JT, Hedley Whyte ET (1997) Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86:113-120
26. Hsu S-M, Raine L, Fanger H (1982) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580
27. Hunter WM, Greenwood FC (1962) Preparation of iodine-131 labelled human growth hormone of high specific activity, Nature, pp 495-496
28. Jay JR, MacLaughlin DT, Rilev KR, Martuza RL (1985) Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 62:757-762
29. Kallio M, Sankila R, Hakulinen T, Jääskeläinen J (1992) Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31:2-12
30. Kumar PP, Patil AA, Leijbrock LG, Chu W, Syh J, McCaul GF, Reeves MA (1991) Brachytherapy: a viable alternative in the management of basal meningiomas. Neurosurgery 29:676-680
31. Lowry OH, Rosebrough NJ, Farr LA, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
32. Mahajan DK, London SN (1997) Mifepristone (RU486): a review. Fertil Steril 68:967-976
33. Norlén BJ, Andersson SB, Björk P, Gunnarsson PO, Fritjofsson Å (1988) Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer. J Urol 140: 1058-1062
34. Olson JJ, Beck DW, Schlechte J, Loh P-M (1986) Hormonal manipulation of meningiomas in vitro. J Neurosurg 65:99-107
35. Perrot Applanat M, Groyer Picard MT, Kujas M (1992) Immunocytochemical study of progesterone receptor in human meningioma. Acta Neurochir (Wien) 115:20-30
36. Sandström PE, Jonsson O, Grankvist K, Henriksson R (1994) Identification of potassium flux pathways and their role in the cytotoxicity of estramustine in human malignant glioma, prostatic carcinoma and pulmonary carcinoma cell lines. Eur J Cancer 12: 1822-1826
37. Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann N Y Acad Sci 51:660-672
38. Schoultz E von, Lundblad D, Bergh J, Grankvist K, Henriksson R (1988) Estramustine binding protein and anti-proliferative effect of estramustine in human cancer cell lines. Br J Cancer 58:326-329
39. Schoultz E von, Grankvist K, Gustavsson H, Henriksson R (1991) Effects of estramustine on DNA and cell membrane in malignant glioma cells. Acta Oncol 30:719-723
40. Schoultz E von, Bergenheim T, Grankvist K, Henriksson R (1991) Estramustine binding protein in human brain-tumor tissue. J Neurosurg 74:962-964
41. Schoultz E von, Carlstrom K, Henriksson R, Lagerlöf B, Hansson J (1994) Estramustine binding protein in primary tumours and metastases of malignant melanoma. Melanoma Res 4:401-405
42. Speirs V, Boyle Walsh E, Fraser WD (1997) Constitutive coexpression of estrogen and progesterone receptor mRNA in human meningiomas by RT-PCR and response of in vitro cell cultures to steroid hormones. Int J Cancer 72:714-719
43. Steams ME, Tew KD (1988) Estramustine binds MAP-2 to inhibit microtubule assembly in vitro. J Cell Sci 89:331-342
44. Stearns ME, Wang M, Tew KD, Binder LI (1988) Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells. J Cell Biol 107:2647-2656
45. Taylor BW, Marcus RB, Friedman WA, Ballinger WE, Millon RR (1988) The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15:299-304
46. Waelti ER, Markwalder TM (1989) Immunocytochemical evidence of progesterone receptors in human meningiomas. Surg Neurol 31:172-176
47. Yoshida D, Piepmeier J, Weinstein M (1994) Estramustine sensitizes human glioblastoma cells to irradiation. Cancer Res 54: 1415-1417